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Abstract
Mitochondria are indispensable in the life and death of many types of eukaryotic cells. In pancreatic beta cells, mitochondria
play an essential role in the secretion of insulin, a hormone that regulates blood glucose levels. Unregulated blood glucose
is a hallmark symptom of diabetes. The onset of Type 1 diabetes is preceded by autoimmune-mediated destruction of beta
cells. However, the exact role of mitochondria has not been assessed in beta cell death. In this study, we examine the role of
mitochondria in both Fas- and proinflammatory cytokine-mediated destruction of the human beta cell line, bLox5. IFNc
primed bLox5 cells for apoptosis by elevating cell surface Fas. Consequently, bLox5 cells were killed by caspase-dependent
apoptosis by agonistic activation of Fas, but only after priming with IFNc. This beta cell line undergoes both apoptotic and
necrotic cell death after incubation with the combination of the proinflammatory cytokines IFNc and TNFa. Additionally,
both caspase-dependent and -independent mechanisms that require proper mitochondrial function are involved.
Mitochondrial contributions to bLox5 cell death were analyzed using mitochondrial DNA (mtDNA) depleted bLox5 cells, or
bLox5 r
0 cells. bLox5 r
0 cells are not sensitive to IFNc and TNFa killing, indicating a direct role for the mitochondria in
cytokine-induced cell death of the parental cell line. However, bLox5 r
0 cells are susceptible to Fas killing, implicating
caspase-dependent extrinsic apoptotic death is the mechanism by which these human beta cells die after Fas ligation.
These data support the hypothesis that immune mediators kill bLox5 cells by both mitochondrial-dependent intrinsic and
caspase-dependent extrinsic pathways.
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Introduction
Insulin-dependent, or Type 1 Diabetes Mellitus (T1D) results as
a consequence of the specific autoimmune destruction of the
pancreatic islet beta cells. While better understood in animal
models, the exact progression to T1D in humans remains elusive,
in part due to the limited human pancreatic samples available for
research and the fact that the islets collected are obtained
postmortem resulting in variable quality and functional capacity
[1]. Consequently, animals that develop diabetes spontaneously
and resemble the human form of the disease, like the NOD mouse
and the BB-DP rat, as well as beta cell lines derived from murine
sources, are heavily relied upon for a mechanistic understanding of
the pathogenesis of the disorder [2].
Studies performed using animal models of T1D as well as
primary human donor islets have proposed several direct and
indirect mechanisms of beta cell destruction. For instance, in the
NOD mouse, insulitis begins with the activation of macrophages
and dendritic cells (DC) within the pancreatic islets. These resident
specialized antigen-presenting cells locally produce chemokines
and cytokines that recruit and activate autoreactive T and B
lymphocytes [3]. Additionally, soluble mediators, such as cytokines
and free radicals, both reactive nitrogen species (RNS) and
reactive oxygen species (ROS) produced by the infiltrating
immune cells and the beta cell themselves, can lead to beta cell
death. In previous studies, IL-1b, IFNa, TNFa, and type 1
cytokines (IFNc, TNFb, IL-2, and IL-12) were found to correlate
with destructive insulitis in the T1D prone NOD mouse and the
BB rat [4]. Pancreatic samples from patients with T1D were also
shown to contain the cytokines IFNa and IFNc, TNFa-producing
lymphocytes, as well as TNFa and IL-1b-expressing macrophages
and DCs [5].
In vitro studies on the cytotoxicity of cytokines to beta cells
suggest that individual proinflammatory cytokines can either
enhance or inhibit beta cell insulin secretion depending on dose
and length of exposure. However, when added in combinations,
IL-1b, IFNc, TNFa induce death and dysfunction of both human
and rodent islets [6]. The impact of cytokines on mouse and rat
islets is mainly through nitric oxide (NO)-mediated necrosis with
minor contributions of apoptosis [6–16]. Studies reporting
observations after exposing human islets to cytokines have been
less clear, likely due to differences in experimental systems [17] as
well as the health of the isolated human islets used [18,19]. Taken
together, it is rational to propose that when treated with cytokines,
human islets die by both necrotic and apoptotic mechanisms.
Furthermore, these cytokines can either alone or in combination
change the surface of islet cells, thereby enhancing the potential
for immune surveillance by cytotoxic T cells. Predictably,
molecules elevated by cytokines, such as MHC class I and Fas,
have been correlated with destructive insulitis in both the mouse
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combined with the fact that T1D is considered to be a T cell
dependent disorder, imply that, in vivo, cytokines are responsible
for providing an inflammatory environment conducive for T cell
recognition and destruction of the insulin-producing cells. In this
proinflammatory milieu, recognition of autoantigens by activated
cytotoxic T cells (CTL) leads to direct beta cell lysis. CTL specific
killing mechanisms that are thought to be involved in beta cell
destruction include the Fas/FasL pathway and perforin/gran-
zyme release. Also, analyses of pancreatic tissues of patients with
T1D show Fas expression mainly in the remaining beta cells of
the islets, and FasL expression in the infiltrating T lymphocytes
[20,21].
Most of these studies have been performed using both beta cells
and CTLs derived from animal models. Yet, the appreciated
genetic and immunopathologic differences between animal models
of the disease and humans attest that diabetogenesis in humans
could be distinctive and highlights the need for a human beta cell
line that can be used for the study of death in the context of
autoimmune-mediated destruction. In this report, we test the
usefulness of a cell line derived from purified adult beta cells,
bLox5 [22], in assays of beta cell death, as well as the
mitochondrial contributions to human beta cell killing by immune
effectors. We exposed bLox5 cells to direct killing by an activating
human Fas antibody, CH11, in addition to indirect killing by the
proinflammatory cytokines IFNc and TNFa. The data presented
show that similar to primary islets and beta cell lines derived from
animals, bLox5 cells are killed after ligation of Fas by caspase-
dependent apoptosis, whereas these cells die by caspase-dependent
and –independent apoptosis together with necrosis after incuba-
tion with TNFa and IFNc. Importantly, bLox5 cells depleted of
their mitochondrial DNA were resistant to proinflammatory
cytokine-induced killing, implicating a role for mitochondria
associated cell death mechanisms in the progression to T1D in
humans.
Results
Agonistic activation of Fas kills bLox5 cells by caspase-
dependent apoptosis
bLox5 cells were incubated for 48 hours with a-Fas mono-
clonal antibody (CH11) alone or in combination with rhIFNc.
The combination of CH11 and rhIFNc induced death of the
bLox5 cells (Fig. 1A), while neither CH11 nor rhIFNc were
alone effective. rhIFNc was required for Fas induced cell death
as it increased Fas expression on the cell surface, even at the
lowest level of rhIFNc tested (Fig. 1B). Because bLox5 cells
treated with rhIFNc had a reduction in absorbance during the
MTT assay, we performed the ApoGlow assay to distinguish
between inhibition of proliferation and cell death. rhIFNc
treatment of bLox5 cells lowered ATP levels with little or no
change in the ADP to ATP ratios corresponding with arrested
proliferation (Fig. 2).
To determine the mechanism of a-Fas-induced killing of bLox5
cells, caspase activity was assayed. Caspases 8 and 3 were shown to
be active after only 24 hours of treatment (Fig. 3A). Pan-caspase
inhibitor Z-VAD-FMK (50 mM) was added to cells 1 hour prior to
and again 24 hours after initiation of rhIFNc and CH11
treatment. When compared to rhIFNc control samples, caspase
inhibition increased cell survival to control levels (Fig. 3B) and
eliminated DNA damage (Fig. 3C). These data clearly implicate
caspase-induced apoptosis as the necessary pathway in Fas-
mediated killing of bLox5 cells.
Proinflammatory cytokine-induced killing of bLox5 cells
occurs through caspase-dependent and –independent
apoptosis and necrosis
bLox5 cells were also susceptible to proinflammatory cytokine-
mediated cell death. Treatment of these cells with the combination
of rhTNFa and rhIFNc for 48 hours caused significant killing
(Fig. 4); however, neither of these cytokines alone was sufficient to
kill bLox5 cells. Similar to NOD derived NIT-1 beta cells, the
addition of IL-1b to the combination is dispensable [23,24].
Consequently, NO was not detected in the supernatant when
measured indirectly via the Greiss Reaction. In addition, Heat
Shock Proteins (HSPs), specifically HSP70 and HSP27 (Fig. S1),
which have been shown to protect beta cells against proinflam-
matory cytokine induction of Nitric Oxide Synthase (iNOS) and
subsequent production of NO [8,9,15,25,26], were expressed in
Figure 1. bLox5 cells are susceptible to a-Fas monoclonal
antibody after rhIFNc priming. A. bLox5 cells were treated with
rhIFNc alone or the combination of a-Fas antibody clone CH-11
(0.5 mg/mL) and rhIFNc (1000 U/mL) for 48 h. Viability was measured
by the MTT assay. ** denotes statistical significance, p,0.005. B.
Overnight priming of bLox5 cells with rhIFNc increases the expression
of surface Fas similarly with 250 U/mL (light gray line), 500 U/mL (gray
line), or 1000 U/mL (dark gray line) of rhIFNc when compared to
untreated control cells (black line).
doi:10.1371/journal.pone.0020617.g001
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significantly upregulated by rhIFNc and the combination of
rhIFNc and rhTNFa. Because rhIFNc was shown to inhibit
proliferation of bLox5 cells, we tested the effects of rhTNFa on the
proliferation of these cells using a tritiated thymidine (
3H-TdR)
incorporation assay. In contrast to rhIFNc, rhTNFa-treated cells
(1000 U/mL or 5000 U/mL) incorporated the same amount of
3H-TdR after 24 and 48 hours as untreated cells (Data Not
Shown).
Treatment of bLox5 cells with rhIFNc and rhTNFa resulted in
activation of Caspases 8 and 3 (Fig. 4B). Confirmed pan-caspase
inhibition failed to completely prevent death (Fig. 4C, D),
suggesting that cytokines kill these cells by multiple pathways.
Accordingly, flow cytometric and Comet assay analyses of
cytokine-induced bLox5 killing indicated that these cells die by
apoptosis and necrosis (Fig. 4A, C). Although caspase inhibition
significantly improved bLox5 viability when measured by the
MTT assay, levels did not reach rhIFNc control (Fig. 4D) and
DNA damage was still observed (Fig. 4C). Protein levels of
phosphorylated p53 (S15) increased with pan-caspase inhibition
(Fig. 5), indicating an enhanced effort to repair DNA damage.
Cell death in bLox5 cells was preceded by an increase in the pro-
apoptotic protein SMAC/Diablo (Fig. 5). SMAC/Diablo con-
tributes to the caspase cascade by binding to inhibitors of apoptosis
(IAPs), such as XIAP [27]. As a result, pro-caspase 3 levels
decreased, while cleaved caspase 3 increased (Fig. 5).
Apoptotic and necrotic bLox5 cell death after cytokine
treatment and caspase inhibition were further analyzed by the
ApoGlow assay and detection of passively released High Mobility
Group 1 (HMGB1), which has been demonstrated to only be
released during primary necrosis [28–30]. The ApoGlow assay
showed signatures of apoptosis, including reductions in ATP levels
of cytokine treated groups with and without pan-caspase inhibition
compared to rhIFNc controls, and significant increases in the ADP
to ATP ratios that did not differ between the cells treated with
rhTNFa and rhIFNc (Fig. 6A). These results indicate that the
improved viability after pan-caspase inhibition measured by the
MTT assay was not biologically significant and apoptosis was still
taking place. Necrosis was confirmed by the presence of HMGB1
only in the supernatant of cytokine-treated bLox5 cells, compared
to untreated and rhIFNc control cells (Fig. 6B).
To examine the contribution of caspase-independent, proapop-
totic molecules, Apoptosis Inducing Factor (AIF) localization was
visualized by immunofluorescence. Compared to rhIFNc controls,
more AIF was present in the nucleus of rhIFNc and rhTNFa-
treated cells (Fig. 7). This suggests that AIF is involved in the
demise of bLox5 cells that occurs in the presence of proin-
flammatory cytokines. Inhibition studies to further understand the
mechanisms of bLox5 cell death showed that these do not depend
on Bax translocation, or Cathepsin B activity (Data Not Shown).
Mitochondrial-DNA deficient bLox5 cells are resistant to
cytokine killing but sensitive to Fas
To examine the role of the mitochondria in cytokine-induced
killing of bLox5 cells, the cell line was depleted of mitochondrial-
DNA (bLox5 r
0) using low levels of EtBr. PCR and confocal
imaging of the cells confirmed successful depletion of the mtDNA
(Fig. 8). Treated and untreated bLox5 cells amplified primers
specific for the nuclear-encoded human Catalase gene (Fig. 8A),
but only untreated cells amplified mtDNA-specific primers
(Fig. 8B). A mitochondrial marker, TMRM, was used to identify
the mitochondria, and picogreen was used as a DNA dye to
identify cytoplasmic DNA. Co-localization of the red TMRM and
green picogreen in the untreated cells was indicative of the
presence of DNA in the mitochondria (Fig. 8C). However, EtBr
treated cells did not co-localize the fluorescent dyes (Fig. 8D).
Viability of bLox5 r
0 cells after cytokine treatment was
measured by the MTT assay and confirmed by FACS analysis
of PI exclusion. bLox5 r
0 cells were found to be resistant to
cytokine-mediated cell death but sensitive to Fas-induced killing
(Fig. 9A), supporting activation of the extrinsic pathway by Fas
versus the intrinsic pathway by proinflammatory cytokines.
mtDNA sufficient bLox5 Cybrid cells were sensitive to Fas
ligation and add-back of mtDNA resulted in regained susceptibility
to proinflammatory cytokines (Fig. 9A). Pan-caspase inhibition
was able to prevent Fas-induced cell death in r
0 and Cybrid cells
(Fig. 9A). Because the mitochondrial electron transport chain is
the main source of ROS in cells, we analyzed the redox state of the
parental cell line, bLox5, after cytokine treatment. Reductions in
available GSH were observed after 24 h of cytokine treatment
(Fig. 9B) when no changes in cell survival have been noted.
Discussion
A human beta cell line that can be expanded and maintained
indefinitely would be a useful tool for advancing our understand-
ing of the autoimmune pancreatic beta cell destruction that
precedes Type 1 diabetes development in man. Such a model cell
Figure 2. rhIFNc alone causes arrested proliferation. bLox5 cells were treated with rhIFNc (1000 U/mL) for 48 h. Cell death profile was
analyzed by the ApoGlow assay. NS denotes no statistical difference.
doi:10.1371/journal.pone.0020617.g002
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inhibitors or genetic manipulations intended to block killing by
autoimmune effectors, or invasively study the impact of immuno-
suppressive agents, hyperglycemia, or hyperlipedemia. To date,
there have been publications detailing the production of six
human derived beta cell lines. These lines are NAKT-15 [31], CM
and HP62 [32–40], NES Y2 [41], TRM-6 [42] and bLox5
[22,42–46]; however, only bLox5 is readily available to the
scientific community. We sought to determine the value of this
already established, human pancreatic beta cell-derived line,
bLox5, in studies aimed at elucidating the role of mitochondria in
human beta cell death induced by immune insults.
The Fas/FasL pathway has been associated with the develop-
ment of T1D in animal models and in humans [20,21,47–49].
Although autoreactive T cell clones from transgenic mice lysed
Fas-deficient islets, presumably due to perforin release, perforin-
deficient T cells had similar diabetogenic potential as the wild type
clones when transferring disease to immunodeficient NOD mice
[20,50]. These findings suggest that redundant mechanisms
eliminate beta cells during the autoimmune attack. To mimic
Figure 3. Fas-induced killing is caspase-dependent. A. bLox5 cells were primed overnight with rhIFNc (1000 U/mL) then left untreated or
treated with a-Fas antibody clone CH-11 (0.5 mg/mL) for an additional 24 h before the activities of Caspases 8 and 3 were measured by FACS
analysis. Increased Caspase 8 and 3 activities were noted after only 24 h of Fas stimulation. A representative plot is shown. B&C . bLox5 cells were
treated with rhIFNc alone or the combination of a-Fas antibody clone CH-11 (0.5 mg/mL) and rhIFNc (1000 U/mL) for 48 h with and without pan-
caspase inhibition with Z-VAD-FMK (50 mM x 2). Viability was measured by the MTT assay (B). *** denotes statistical significance with a P value
,0.0001. NS denotes no statistical difference. DNA damage after treatment with and without caspase inhibition was assessed by the Comet Assay (C).
doi:10.1371/journal.pone.0020617.g003
Immune Mediated Human Beta Cell Death
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with an activating a-Fas monoclonal antibody for 48 h. The 48 h
treatment period was chosen to obtain a significant amount of cell
death while still having the required cell numbers to perform
functional assays, such as measuring caspase activity in apoptotic
and live cells. In addition, because bLox5 cells proliferate well,
longer incubation times in 12-well plates leads to death even in
untreated cells.
Similar to primary islets from human and mouse as well as
rodent derived beta cell lines, bLox5 cells required rhIFNc
priming for sufficient surface Fas expression and subsequent
ligation by the antibody (Fig. 1), supporting the role of
proinflammatory cytokines in providing an environment favorable
for cell killing [51]. Moreover, Fas-dependent apoptosis in bLox5
cells was found to be caspase mediated (Fig. 3). mtDNA deficient
bLox5 r
0 cells, which are deficient in the electron transport chain
subunits of Complexes, I, III, and IV that are encoded by the
mtDNA, were sensitive to Fas ligation due to the activation of
caspases (Fig. 9A). This is in accordance with the extrinsic type I
model of Fas-mediated apoptosis that proceeds independent of the
mitochondria [52], and with Fas-mediated killing mechanisms
previously identified in the NIT-1, NOD insulinoma cells, and
primary NOD islets [53,54]. These results indicate that bLox5
cells are susceptible to direct killing by immune effectors and die
by a relevant pathway in T1D.
Proinflammatory cytokine exposure of primary rat or mouse
pancreatic islets as well as the RIN and INS1 beta cell lines,
established from rat, results in functional inhibition and death that
is highly dependent upon the production of NO [12] with small
contributions of apoptosis only after long-term culture with
cytokines [13]. In mouse beta cell lines, killing due to IFNc,
TNFa and IL-1b treatment is less dependent on NO production
and in some cell lines death is NO independent [55,56]. In human
islets, timing of treatment as well as cytokine combination and
dose are critical [11,17]. To test if bLox5 cells are also vulnerable
to proinflammatory cytokines, we cultured the cells with rhIFNc,
rhTNFa and rhIL-1b individually or in combination. We found
that the combination of rhIFNc and rhTNFa led to the most
significant level of bLox5 cell death by both apoptosis and necrosis
(Fig. 4). Cytokines promoted both necrosis and caspase-depen-
dent apoptosis of bLox5 cells that was independent of NO,
potentially due to the presence of HSP27 and HSP70 (Fig. S1),
confirming that proinflammatory cytokines can activate a range of
pro-death mechanisms in beta cells [5,10,13,17,53–55,57–63].
Beta cell mitochondria play a key role in insulin secretion [64]
and may be important in beta cell death. Apoptosis-inducing
stimuli result in the mitochondrial membrane permeability
transition (PT) that leads to the release of Cytochrome c (Cyt c)
and other proapoptotic molecules. PT and Cyt c release generally
precede the disruption of mitochondrial inner membrane potential
(DYm) and mitochondrial function [65]. In addition, mitochon-
drial release of proapoptotic molecules potentiates the activation
cascade of caspases [66]. Although caspases are involved in the
killing of bLox5 cells by proinflammatory cytokines (Figs. 4 & 5),
other pathways are also implicated, as the pan-caspase inhibitor,
Z-VAD-FMK, failed to completely prevent death in these cells
(Figs. 4 & 6). Necrosis was shown to contribute to bLox5
cytokine-induced death (Figs. 4 & 6) and could have accounted
Figure 4. Cytokine-induced cell death is partially caspase-dependent. A, B, C & D. bLox5 cells were treated with the combination of
rhTNFa (2000 U/mL) and rhIFNc (1000 U/mL) for 48 h with and without pan-caspase inhibition with Z-VAD-FMK (50 mM x 2). The cell death profile (A)
as well the activities of Caspases 8 and 3 (B) were measured by FACS analysis. A representative plot is shown. DNA damage and death were assessed
via the Comet Assay (C) and the MTT Assay (D), respectively. ** denotes statistical significance with a P value ,0.005.
doi:10.1371/journal.pone.0020617.g004
Figure 5. Apoptosis and DNA repair protein expression of cytokine-treated bLox5 cells. bLox5 cells were treated with the combination of
rhTNFa (2000 U/mL) and rhIFNc (1000 U/mL) for 24 h with and without pan-caspase inhibition with Z-VAD-FMK (50 mM). The Proteome Profiler
Human Apoptosis Array Kit was used for protein detection. Proteins of interest are shown.
doi:10.1371/journal.pone.0020617.g005
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of apoptosis, was still observed with pan-caspase inhibited cells
(Figs. 4 &5). Therefore, caspase-independent mechanisms of
apoptosis were investigated. Apoptosis Inducing Factor (AIF) is a
caspase-independent, proapoptotic molecule that acts through its
release from the mitochondria and subsequent translocation to the
nucleus, where it binds DNA and causes chromatin condensation
[67,68]. In order to determine if AIF is involved in cytokine killing
of bLox5 cells, treated cells were visualized for AIF localization.
The ratio of nuclear localized AIF to cytoplasmic AIF was
significantly increased in cytokine-treated cells (Fig. 7). This
difference persisted in Z-VAD-FMK pre-treated bLox5 cells,
supporting a role for AIF in rhIFNc and rhTNFa cytotoxicity.
Other caspase-independent pro-apoptotic pathways were stud-
ied for their role in cytokine-mediated bLox5-cell death.
Cathepsin B has been shown to contribute to TNFa-induced
apoptosis in other cell types [69]; however, Cathepsin B inhibition
with CA 074 failed to rescue bLox5 survival after cytokine
treatment. In fact, at the published concentration of 20 mM [69],
CA 074 exacerbated cytokine killing and caspase activation (Data
Not Shown). At the highest non-toxic concentration of 5 mM, CA
074 did not increase survival. Recently, Bax-dependent mito-
chondrial permeabilization was identified as a pro-apoptotic signal
in human islets after cytokine treatment [17]; nonetheless,
preventing Bax translocation into the mitochondria was insuffi-
cient to prevent death in bLox5 cells (Data Not Shown).
mtDNA deficient bLox5 r
0 cells were not killed by rhIFNc and
rhTNFa treatment but mtDNA sufficient bLox5 Cybrid cells were
sensitive to cytokine-induced cell death (Fig. 9A). This is
Figure 7. Cytokine treatment of bLox5 promotes nuclear
translocation of Apoptosis Inducing Factor. bLox5 cells were
treated with the combination of rhTNFa (2000 U/mL) and rhIFNc
(1000 U/mL) for 48 h with and without pan-caspase inhibition with Z-
VAD-FMK (50 mM x 2). Immunofluorescence analysis shows increased
AIF translocation to the nucleus in cytokine treated cells. Representative
images are shown. White arrows indicate cells with high nuclear AIF
staining. *denotes statistical significance with a P value ,0.05. NS
denotes no statistical difference.
doi:10.1371/journal.pone.0020617.g007
Figure 6. bLox5 cells die by apoptosis and necrosis after cytokine treatment with and without pan-caspase inhibition. A & B. bLox5
cells were treated with the combination of rhTNFa (2000 U/mL) and rhIFNc (1000 U/mL) for 48 h with and without pan-caspase inhibition with Z-
VAD-FMK (50 mM x 2). Viability was analyzed by the ApoGlow Assay (A). * denotes statistical significance with a P value ,0.05. NS denotes no
statistical difference. The supernatant was analyzed for passive HMGB1 release (B). +: bLox5 cell lysate/positive control, 1: Untreated Control, 2:
rhIFNc, 3: rhIFNc + rhTNFa, 4: rhIFNc + rhTNFa + Z-VAD-FMK.
doi:10.1371/journal.pone.0020617.g006
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apoptosis was activated during cytokine treatment of human islets
[17]. Therefore, because we found that functional mitochondria
are required for IFNc and TNFa killing and mitochondria are a
major source of ROS, we tested the cells for signs of oxidative
stress. GSH levels after cytokine treatment indicated oxidative
stress in these cells (Fig. 9B), demonstrating that cytokine
treatment tilts the redox balance towards oxidation, likely due to
increased ROS production.
The susceptibility of isolated human islets to killing in vitro by
proinflammatory cytokines has been the focus of significant
hypothesis testing, while mechanisms of Fas killing of human
islets has been less intense [70]. Post-mortem histological analysis
of pancreas from patients with T1D have demonstrated that
within the insulitis, CD8
+ T cells express cell surface FasL
suggesting a role for Fas in beta cell destruction during disease
development [71]. Information on how Fas kills islets has been
derived from studies using mouse islets with no clear published
mechanism using human islets. Mouse studies indicated Fas
activated caspases. The enclosed studies are the first demonstra-
tion of a mechanism for Fas mediated apoptosis of human beta
cells, and clearly indicate that Fas activates the extrinsic pathway
for apoptosis in bLox5 cells (Figs. 3 & 9). It remains to be
investigated whether this is a shared mechanism with primary
human islets.
The ultimate effector molecule resulting from a cytokine attack
on primary islets is NO [11]. In contrast to primary human islets,
bLox5 cells do not produce NO when exposed to the combination
of IFNc, TNFa and IL-1b. In the absence of NO production,
IFNc, TNFa and IL-1b can activate a range of pro-death
pathways, including caspase-dependent apoptosis and necrosis, in
isolated primary human islets [17,70]. bLox5 cells undergo both
necrosis and caspase-dependent and –independent apoptosis after
treatment with rhIFNc and rhTNFa. However, IL-1b is required
to kill primary human islets yet, its addition is superfluous for
killing of bLox5 cells. Therefore, this cell line is likely unsuitable as
a model to use in studies of cytokine-induced iNOS-mediated beta
cell killing.
In summary, bLox5 cells are a partially dedifferentiated beta
cell line that produces a lower level of insulin than primary islets
and has blunted glucose stimulated insulin secretion. This cell line
and its derivative line, bLox5 r
0, have been established as
unlimited sources of human beta cells, that are inappropriate to
study mechanisms of beta cell function; however, they can be used
for the study of autoimmune beta cell apoptosis as well as
mitochondrial contributions to cell death. These cells are primed
by proinflammatory cytokines for Fas-induced caspase-dependent
apoptosis via the extrinsic pathway and are susceptible to cytokine-
mediated apoptosis and necrosis through mitochondrial mecha-
nisms that are both caspase-dependent and –independent. We
Figure 8. Confirmation of mtDNA depletion in bLox5 r
0 cells. A. PCR primers specific for a segment of the Catalase gene (CAT) were used as a
positive control. Genomic DNA from both EtBr (100 ng/mL) treated and untreated cell cultures exhibited robust amplification with the CAT primer
pair (product length: 292 bp). B. Using primers that are specific for the human mtDNA we were unable to amplify mtDNA from the EtBr treated cells,
while the untreated cells produced a band of appropriate size (product length: 2372 bp). C. Confocal images of untreated bLox5 cells using the
fluorescent probes picogreen (Green-DNA) and TMRM (Red-mitochondrial membrane potential). Untreated cells exhibit a co-localization (Orange) of
these dyes in the cytoplasm. D. Confocal images of EtBr treated (100 ng/mL) bLox5 cells (bLox5 r
0) using the fluorescent probes picogreen (Green-
DNA) and TMRM (Red-mitochondrial membrane potential). bLox5 r
0 cells exhibit mitochondrial membrane potential but no cytoplasmic positivity for
picogreen.
doi:10.1371/journal.pone.0020617.g008
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direct methods of killing employed by autoimmune effector cells.
Materials and Methods
Cell Line and Reagents
The bLox5 cell line was kindly provided by Dr. Fred Levine
(Sanford Children’s Health Research Center, Sanford-Burnham
Medical Research Institute, La Jolla, CA). bLox5 cells were
maintained in low glucose (1 mg/mL) DMEM (Cellgro, Manassas,
VA), supplemented with 10% FBS (HyClone, Fisher Scientific,
Pittsburgh, PA), 1% MEM non-essential amino acids (Cellgro), 1%
penicillin-streptomycin (Gemini Bio-Products, West Sacramento,
CA) solution, 0.02% BSA (Sigma, St. Louis, MO) and 15 mM
HEPES (Cellgro) (VC-DMEM). Recombinant human IFNc was
obtained from BD Biosciences (San Jose, CA). Recombinant
human TNFa and recombinant IL-1b were purchased from R&D
Systems (Minneapolis, MN). Fas agonistic antibody (Clone CH11)
was purchased from Millipore (Temecula, CA). A monoclonal
antibody to HMGB1 was acquired from Abcam Inc. (Cambridge,
MA). An antibody to hCD95 (Fas)-PE-Cy5 and the isotype control
were purchased from BD Biosciences. Annexin V-APC was
purchased from Invitrogen (Carlsbad, CA).
Generation of bLox5 r
0 Cells and bLox5 Cybrid Cells
bLox5 r
0 cells were cultured in high glucose (4.5 mg/mL)
DMEM (Cellgro) supplemented with 10% FBS (HyClone, Fisher
Scientific), 1 mM sodium pyruvate (Sigma), 50 mg/L Uridine
(Sigma), and 1% penicillin-streptomycin (Gemini Bio-Products).
mtDNA was depleted by culturing cells in the above medium
supplemented with 100 ng/ml Ethidium Bromide (EtBr) for 6
months. Depletion of mtDNA was confirmed by: 1) PCR; 2)
confocal microscopy imaging; 3) failure of bLox5 r
0 cells to
survive in pyruvate- and uridine-free medium.
Figure 9. Functional mitochondria are required for cytokine killing of bLox5. A. bLox5 r
0 cells (empty bars) and bLox5 Cybrid cells (gray
bars) were treated with rhTNFa (2000 U/mL) and rhIFNc (1000 U/mL) or with CH-11 (0.5 mg/mL) and rhIFNc (1000 U/mL) for 48 h. Z-VAD-FMK
(50 mM x 2) was used to inhibit caspase activity. Viability was measured by the MTT assay. Only mtDNA sufficient cells were killed by cytokines. ***
denotes statistical significance with a P value ,0.0001 compared to rhIFNc control. NS denotes no statistical difference when compared to rhIFNc
control. B. Changes in GSH levels were measured after a 24 h incubation period with rhTNFa (2000 U/mL) and rhIFNc (1000 U/mL), with and without
pan-caspase inhibition. ** denotes statistical significance with a P value ,0.01 compared to rhIFNc control.
doi:10.1371/journal.pone.0020617.g009
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Briefly, cybrid cells were made by fusion of bLox5 r
0 cells with
mtDNA donor platelets from a healthy individual under the
presence of 50% (W/V) polyethylene glycol 1500 (Roche). Cells
were cultured in the medium for bLox5 r
0 cells during the first 3
days after the fusion and then in selective medium (uridine and
pyruvate-free DMEM supplemented with 10% dialyzed FBS,
Penicillin and Streptomycin). After selection for 3 weeks, surviving
cybrid cells were cultured in DMEM for bLox5, as described
above, without pyruvate and uridine. Cybrid cells were cloned
using cloning cylinders (Corning, Corning, NY) when visible
colonies appeared in the culture.
Cell Death Assays. bLox5, r
0 and Cybrid cells were seeded in
twelve-well Corning Costar culture plates (Fisher Scientific) at a
density of 5610
4 cells per well in a total volume of 500 mLa n d
allowed to adhere for 48 hours. The cells were then incubated with
rhTNFa (2000 U/mL) and rhIFNc (1000 U/mL) for 48 hours.
bLox5, r
0 and Cybrid cells were also cultured in the presence of a-
Fas activating antibody CH11 (0.5 mg/mL) with and without
rhIFNc (1000 U/mL). Cell viability was examined using the MTT
assay [73,74], propidium iodide (PI) uptake, and externalization of
phosphatidylserine (PS) by Annexin V-APC staining.
Percent cell survival after cytokine or a-Fas antibody treatment
was measured by determining the ability of the live cells to reduce
yellow MTT, 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide (Sigma), to insoluble purple formazan crystals.
The cells were treated with MTT solution [5 mg/mL in
phosphate buffered saline (PBS)] for 2 hours at 37uC, 5% CO2.
Excess solution was removed and the formazan crystals were then
resuspended in acid isopropanol (0.04 N HCl in isopropanol). The
optical density of the product was measured at a wavelength of
560 nm and background subtracted at 670 nm.
bLox5 cells were analyzed on a BD LSR-Fortessa flow cytometer
using the BD FACSDiva software (BD Biosciences) and FlowJo flow
cytometry analysis software (Tree Star, Inc., Ashland, OR). Cellular
apoptosis was determined by double staining with PI and Annexin
V-APC,whilenecroticcellswereidentifiedasPIsingle positivecells.
In addition, Trevigen’s CometAssay kit (Trevigen Inc, Gaithers-
burg, MD) was used to evaluate DNA damage in treated and
untreated bLox5 cells based on DNA tail shape and migration
pattern. The Proteome Profiler Human Apoptosis Array Kit (R&D
Systems) was utilized to measure the expression of proteins involved
in apoptosis and DNA repair.
Passive release of high-mobility group box 1 (HMGB1) protein
by necrotic cells was determined Western Blot. Briefly, bLox5 cells
were treated as described and the supernatant of each well was
removed without disturbing the attached cells. The supernatant
was concentrated using an ultracentrifuge (100,000 x g for 25
minutes), separated by SDS-PAGE, and then transferred to a
nitrocellulose membrane (Bio-Rad Laboratories, Hercules, CA).
HMGB1 was detected by chemiluminescence (SuperSignal West
Pico Chemiluminescent Substrate Kit, Thermo Scientific, Wal-
tham, MA) according to the manufacturer’s instructions.
Nitric Oxide Detection
The amount of nitric oxide (NO) released by bLox5 cells after
cytokine treatment was indirectly measured using the Griess Reaction
as previously described [14]. The optical density was read using a
SpectraMax M5 plate reader (Molecular Devices, Sunnyvale, CA).
Oxidative Stress Analysis
Glutahione (GSH) levels were detected and quantified with the
GSH-Glo Glutathione Assay (Promega, Madison, WI) after a
24 hour-incubation with rhTNFa (2000 U/mL) and rhIFNc
(1000 U/mL).
Caspase Activity and Inhibition Assays
Caspase-8 and caspase-3 activities were measured using a
commercially available caspase detection kit (Cell Technology,
Inc, Palo Alto, CA) according to the manufacturer’s instructions.
Briefly, caspase-8 (FAM-LETD-FMK) or caspase-3 (FAM-DEVD-
FMK)-specific carboxyfluorescein (FAM) labeled peptide fluoro-
methyl ketone (FMK) caspase inhibitors were incubated with
48 hours cytokine-treated, 24 hours and 48 hours a-Fas-treated, or
untreated control bLox5 cells for 1 hour at 37uC. Cells containing
bound inhibitor were analyzed by flow cytometry on the FL1
channel. In some cases, the cells were treated with 50 mMo ft h e
pan-caspase inhibitor (Z-VAD-FMK), purchased from Calbiochem
(San Diego, CA), for 1 hour prior to treatment. Z-VAD-FMK was
also added after 24 hours of incubation to maintain caspases
inactive. Pretreatment for 1 hour with the specific inhibitor CA 074
(20 mM) (Sigma) was used to inhibit the lysosomal protease
Cathepsin B. Bax translocation into the mitochondria was inhibited
with 100 mM of the peptide V5 (Calbiochem).
Flow Cytometry
Cytokine-treated and untreated bLox5 cells were analyzed for
Fas surface expression by standard flow cytometry techniques. In
brief, bLox5 cells were treated with increasing concentrations of
rhIFNc (250, 500, and 1000 U/mL) for 48 hours, stained for
1 hour at 4uC and washed to remove excess unbound antibody
before analysis.
Immunofluorescence
bLox5 cells were incubated with cytokines as described. Cells
werefixedwith 2%paraformaldehyde(PFA)for10minutesatroom
temperature (RT), permeabilized with 100% ice-cold methanol for
10 minutes, then blocked with 10% Normal Goat Serum (NGS) for
40 minutes at RT with single PBS washes between each step and
two washes before adding the antibody. bLox5 cells were
conjugated with AIF antibody (R&D Systems) for 1 hour at 37uC,
washed 3 times, then stained with FITC conjugated anti-rabbit IgG
(1:200) for 60 minutes in the dark. Before visualization, cells were
washed and slides were covered using 49,6-diamidino-2-phenylin-
dole (DAPI)-containing mounting medium. A Zeiss Axioskop
Microscope was used to visualize and image the cells. Images were
analyzed using ImageJ/Fiji (National Institute of Health).
Statistical analysis
Unless stated otherwise, data are shown as mean 6 SEM.
Significance was determined by a T-test for two group
comparisons (GraphPad Prism 5.02 San Diego, CA).
Supporting Information
Figure S1 Cytokine treatment of bLox5 cells induces the
expression of Heat Shock Proteins. bLox5 cells were treated
with the combination of rhTNFa (2000 U/mL) and rhIFNc
(1000 U/mL) for 24 h with and without pan-caspase inhibition
with Z-VAD-FMK (50 mM). The Proteome Profiler Human
Apoptosis Array Kit was used for protein detection.
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